Header Logo

Connection

Mark Scharf to Acne Vulgaris

This is a "connection" page, showing publications Mark Scharf has written about Acne Vulgaris.
Connection Strength

0.800
  1. Blankenship K, Burns L, Scharf M. Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect. Cutis. 2022 09; 110(3):E19-E20.
    View in: PubMed
    Score: 0.800
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.